English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51496431    線上人數 :  728
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"jia horng kao"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 521-545 / 1180 (共48頁)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-09-04T06:11:07Z Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:07Z Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model JIA-HORNG KAO; Asselah T.; Dou X.-G.; Hamed K.
臺大學術典藏 2021-09-04T06:11:07Z Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway Liu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:06Z NOhep: Toward Global Control of Hepatitis B Virus Infection - An Introduction Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:06Z High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments Nien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; JIA-HORNG KAO; Yang W.-S.
臺大學術典藏 2021-09-04T06:11:06Z Unmet Needs in Clinical and Basic Hepatitis B Virus Research Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:06Z Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO; Chen K.-F.
臺大學術典藏 2021-09-04T06:11:05Z Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in?chronic hepatitis B patients Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:05Z Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D Kao C.-N.; Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:04Z Benefits of long-term therapy with nucleos(t)ide analogues in treatment-na?ve patients with chronic hepatitis B Wei L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:04Z Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study Blach S.; Zeuzem S.; Manns M.; Altraif I.; Duberg A.-S.; Muljono D.H.; Waked I.; Alavian S.M.; Lee M.-H.; Negro F.; Abaalkhail F.; Abdou A.; Abdulla M.; Abou Rached A.; Aho I.; Akarca U.; Al Ghazzawi I.; Al Kaabi S.; Al Lawati F.; Al Namaani K.; Al Serkal Y.; Al-Busafi S.A.; Al-Dabal L.; Aleman S.; Alghamdi A.S.; Aljumah A.A.; Al-Romaihi H.E.; Andersson M.I.; Arendt V.; Arkkila P.; Assiri A.M.; Baatarkhuu O.; Bane A.; Ben-Ari Z.; Bergin C.; Bessone F.; Bihl F.; Bizri A.R.; Blachier M.; Blasco A.J.; Brandao Mello C.E.; Bruggmann P.; Brunton C.R.; Calinas F.; Chan H.L.Y.; Chaudhry A.; Cheinquer H.; Chen C.-J.; Chien R.-N.; Choi M.S.; Christensen P.B.; Chuang W.-L.; Chulanov V.; Cisneros L.; Clausen M.R.; Cramp M.E.; Craxi A.; Croes E.A.; Dalgard O.; Daruich J.R.; De Ledinghen V.; Dore G.J.; El-Sayed M.H.; Ergor G.; Esmat G.; Estes C.; Falconer K.; Farag E.; Ferraz M.L.G.; Ferreira P.R.; Flisiak R.; Frankova S.; Gamkrelidze I.; Gane E.; Garcia-Samaniego J.; Khan A.G.; Gountas I.; Goldis A.; Gottfredsson M.; Grebely J.; Gschwantler M.; Guimaraes Pessoa M.; Gunter J.; Hajarizadeh B.; Hajelssedig O.; Hamid S.; Hamoudi W.; Hatzakis A.; Himatt S.M.; Hofer H.; Hrstic I.; Hui Y.-T.; Hunyady B.; Idilman R.; Jafri W.; Jahis R.; Janjua N.Z.; Jar?u?ka P.; Jeruma A.; Jonasson J.G.; Kamel Y.; JIA-HORNG KAO; Kaymakoglu S.; Kershenobich D.; Khamis J.; Kim Y.S.; Kondili L.; Koutoubi Z.; Krajden M.; Krarup H.; Lai M.-S.; Laleman W.; Lao W.-C.; Lavanchy D.; Lazaro P.; Leleu H.; Lesi O.; Lesmana L.A.; Li M.; Liakina V.; Lim Y.-S.; Luksic B.; Mahomed A.; Maimets M.; Makara M.; Malu A.O.; Marinho R.T.; Marotta P.; Mauss S.; Memon M.S.; Mendes Correa M.C.; Mendez-Sanchez N.; Merat S.; Metwally A.M.; Mohamed R.; Moreno C.; Mourad F.H.; Mullhaupt B.; Murphy K.; Nde H.; Njouom R.; Nonkovic D.; Norris S.; Obekpa S.; Oguche S.; Olafsson S.; Oltman M.; Omede O.; Omuemu C.; Opare-Sem O.; Ovrehus A.L.H.; Owusu-Ofori S.; Oyunsuren T.S.; Papatheodoridis G.; Pasini K.; Peltekian K.M.; Phillips R.O.; Pimenov N.; Poustchi H.; Prabdial-Sing N.; Qureshi H.; Ramji A.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reesink H.W.; Ridruejo E.; Robbins S.; Roberts L.R.; Roberts S.K.; Rosenberg W.M.; Roudot-Thoraval F.; Ryder S.D.; Safadi R.; Sagalova O.; Salupere R.; Sanai F.M.; Sanchez Avila J.F.; Saraswat V.; Sarmento-Castro R.; Sarrazin C.; Schmelzer J.D.; Schreter I.; Seguin-Devaux C.; Shah S.R.; Sharara A.I.; Sharma M.; Shevaldin A.; Shiha G.E.; Sievert W.; Sonderup M.; Souliotis K.; Speiciene D.; Sperl J.; Starkel P.; Stauber R.E.; Stedman C.; Struck D.; Su T.-H.; Sypsa V.; Tan S.-S.; Tanaka J.; Thompson A.J.; Tolmane I.; Tomasiewicz K.; Valantinas J.; Van Damme P.; Van Der Meer A.J.; Van Thiel I.; Van Vlierberghe H.; Vince A.; Vogel W.; Wedemeyer H.; Weis N.; Wong V.W.S.; Yaghi C.; Yosry A.; Yuen M.-F.; Yunihastuti E.; Yusuf A.; Zuckerman E.; Razavi H.; The Polaris Observatory HCV Collaborators
臺大學術典藏 2021-09-04T06:11:03Z Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrast Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:03Z Elimination of Hepatitis B: Is It a Mission Possible? Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:03Z De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline Lin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Wang H.-Y.
臺大學術典藏 2021-09-04T06:11:02Z Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:02Z Urgency to treat patients with chronic hepatitis C in Asia JIA-HORNG KAO; Ahn S.H.; Chien R.-N.; Cho M.; Chuang W.-L.; Jeong S.-H.; Liu C.-H.; Paik S.-W.
臺大學術典藏 2021-09-04T06:11:02Z Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir Liu C.-H.; Chen Y.-S.; Wang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:01Z Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:01Z Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:01Z HBV markers for HCC prediction: Three heads are better than two? Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:01Z More viral mutants, less HBsAg clearance? One size may not fit all Tseng T.-C.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:00Z An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia Hsu C.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:00Z Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; JIA-HORNG KAO; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T.
臺大學術典藏 2021-09-04T06:10:59Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:10:59Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO; Liu C.-J.

顯示項目 521-545 / 1180 (共48頁)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每頁顯示[10|25|50]項目